Further follow up of the cardiomyopathic patient treated by intracoronary administration of autologous mesenchymal stem cells

Pediatric Transplantation

Volumn 15, Issue 4, 2011, Pages 442-

  Zeinaloo, Ali Akbar ^a   Zanjani, Keyhan Sayadpour ^a   Khosroshahi, Ahmad Gamei ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; INOTROPIC AGENT;

ANTICOAGULANT THERAPY; AUTOLOGOUS MESENCHYMAL STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOMYOPATHY; COHORT ANALYSIS; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; LETTER; MESENCHYMAL STEM CELL TRANSPLANTATION; SEPTICEMIA;

CARDIOMYOPATHIES; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 79957515387     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01509.x     Document Type: Letter

References (3)

1. Zeinaloo A, Zanjani KS, Bagheri MM, Mohyeddin-Bonab M, Monajemzadeh M, Arjmandnia MH,. Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy. Pediatr Transplant 2010: Epub ahead of print.
2. Strauer BE, Yousef M, Schannwell CM,. The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: The STAR-heart study. Eur J Heart Fail 2010: 12: 721-729.
3. Rupp S, Bauer J, Tonn T, et al., Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy. Pediatr Transplant 2009: 13: 620-623.